UPS has completed the acquisition of Frigo-Trans and its sister company BPL, which provide complex healthcare logistics across Europe.

The acquisitions further enhance the end-to-end capabilities available to UPS Healthcare customers, who increasingly need temperature-controlled and time-critical logistics globally.

Frigo-Trans’ network includes temperature-controlled warehousing ranging from cryopreservation (-196˚C) to ambient (+15 to +25˚C) as well as pan-European cold chain transportation. This combined with the logistics offerings brought by BPL’s time-critical freight forwarding capabilities enhances UPS Healthcare for customers in Europe.

Frigo-Trans provides end-to-end warehouse and transportation for pharmaceutical and biotech customers. It does this by using distribution facilities and a pharmacy-focused, pan-European, cold-chain transportation network. Other value-added services include packaging, handling and inventory management.

Headquartered in Fußgönheim, Germany, Frigo-Trans (www.frigo-trans.de) has a network across all countries in Europe.

BPL (www.bplogistics.de) offers individual transport management for GDP-compliant shipping of time-critical and temperature-sensitive products. BPL manages a network of air and ocean freight carriers along with customs clearance to meet complex, cross border needs. It prioritises serving biopharma customers with special temperature, quality and speed requirements, and is headquartered in Duesseldorf, Germany.

UPS (www.ups.com) had 2023 revenue of $91bn, and provides a broad range of integrated logistics for customers in more than 200 countries and territories.

UPS Healthcare (Healthcare.ups.com) delivers healthcare logistics expertise to its customers around the world. Services include inventory management, cold chain packaging and shipping, storage and fulfilment of medical devices, and lab and clinical trial logistics.